Diferencia entre revisiones de «Eosinophilic granulomatosis with polyangiitis»

Sin resumen de edición
 
(No se muestran 3 ediciones intermedias de 2 usuarios)
Línea 1: Línea 1:
==Background==
==Background==
*Formerly known as Churg-Strauss syndrome
*Formerly known as Churg-Strauss Syndrome
*Chronic [[sinusitis]], [[asthma]], and peripheral [[eosinophilia]]
*Chronic [[sinusitis]], [[asthma]], and peripheral [[eosinophilia]]
*Vasculitis of small and medium sized vessels
*Vasculitis of small and medium sized vessels
*Lung and skin are most commonly involved
*Lung and skin are most commonly involved
{{Primary Vasculitis DDX}}


==Clinical Features==
==Clinical Features==
Línea 37: Línea 39:
*[[Methotrexate]]
*[[Methotrexate]]
*Leflunomide
*Leflunomide
*[[Inhaled corticosteroids]]
*[[Inhaled corticosteroid]]s


==Disposition==
==Disposition==
Línea 43: Línea 45:


==See Also==
==See Also==
*[[Vasculitis syndromes]]
*[[Granulomatosis with polyangiitis]]


==External Links==
==External Links==

Revisión actual - 17:44 2 ago 2023

Background

  • Formerly known as Churg-Strauss Syndrome
  • Chronic sinusitis, asthma, and peripheral eosinophilia
  • Vasculitis of small and medium sized vessels
  • Lung and skin are most commonly involved

Vasculitis Syndrome Types

Clinical Features

Classically develops in three sequential phases:

  1. Prodrome
  2. Eosinophilic phase
    • Multiorgan involvement, particularly lung and GI tract
    • Caused by eosinophilic infiltration into these organs
  3. Vasculitic phase
    • Life threatening vasculitis associated with vascular and extravascular granulomatosis
    • May present with nonspecific signs such as fever, weight loss, malaise

Differential Diagnosis

Evaluation

  • Typically a clinical diagnosis
  • Labs with elevated eosinophils, ESR, CRP, ANCA
  • CXR with transient, patchy opacities

Management

Acute Therapy

Maintenance Therapy

Disposition

  • Refer to rheumatology

See Also

External Links

References